Mithra Pharmaceuticals SA (MITRA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mithra Pharmaceuticals SA (MITRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8093
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the treatment of contraception and fertility, menopause and osteoporosis, gynecological infections and cancers, among others. Mithra offers its products in polymeric forms, sterile injectable products, and hormonal tablets. It also offers research, development and specialist manufacturing services. The company sells its products through a network of distributors in Belgium, France, Germany and Brazil, among others. Mithra is headquartered in Liege, Belgium.

Mithra Pharmaceuticals SA (MITRA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Mithra Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 10
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Mithra Pharma Acquires Estetrol from Pantarhei Bioscience 13
Mithra Pharma Acquires Women Health Portfolio from Uteron Pharma 14
Partnerships 15
Mithra Pharma Enters into Agreement with Generic Specialty Pharma 15
Licensing Agreements 16
Pei Li Pharma Enters into Licensing Agreement with Mithra Pharma 16
Richter Gedeon Enters into Licensing Agreement with Mithra Pharma 17
Mediner Enters into Licensing Agreement with Mithra Pharma 18
Searchlight Pharma to Enter into Licensing Agreement with Mithra Pharma 19
Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 20
Fuji Pharma Enters into Licensing Agreement with Mithra Pharma for Donesta 21
Mithra Pharma Enters into Licensing Agreement for Tibelia in Canada 22
Equity Offering 23
Mithra Pharma Raises USD90 Million in Private Placement of Shares 23
Mithra Pharma Raises USD29 Million in Private Placement of Shares 25
Mithra Pharma Raises USD81.4 Million in IPO 26
Asset Transactions 27
Ceres Pharma to Acquire Women’s Health Generic Business from Mithra Pharma 27
Mithra Pharmaceuticals SA – Key Competitors 28
Mithra Pharmaceuticals SA – Key Employees 29
Mithra Pharmaceuticals SA – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Sep 25, 2018: Mithra announces 2018 half year results 31
Mar 02, 2018: Mithra Reports 2017 Annual Results 36
Sep 21, 2017: Mithra Announces 2017 Half Year Results 41
Mar 02, 2017: Mithra Pharmaceuticals: Mithra reports 2016 annual results 42
Corporate Communications 45
Mar 03, 2017: Mithra signs agreement with Fuji Pharma to commercialise Donesta 45
Jan 19, 2017: USPTO issues Notice of Allowance for Mithra’s application for Estetrol patent 46
Jan 12, 2017: Mithra Pharmaceuticals sets up scientific advisory boards for Donesta 47
Jan 06, 2017: Mithra Pharmaceuticals Appoints Christophe Marechal As Chief Financial Officer 48
Government and Public Interest 49
Feb 13, 2017: Mithra Pharmaceuticals: Mithra Granted EUR 1.9 Million In Non-Dilutive Funding 49
Product News 50
01/12/2017: Mithra’s North American Advisory Board For Donesta to Meet In Miami, Florida 50
Product Approvals 51
Jun 09, 2017: Mithra Receives Orphan Drug Designation From EMA For E4 In Neonatal Encephalopathy 51
Clinical Trials 52
May 03, 2018: Mithra Announces Last Subject Visit in Estelle Phase III Study in EU/Russia and Completion of Endometrial Substudy 52
Mar 23, 2018: Mithra Announces Completion Of Estelle Cycles Required In Phase Iii Contraception Studies 53
Feb 08, 2018: Mithra Announces Very Promising Hemostasis Results for Estelle 54
Nov 30, 2017: Mithra Provides Update On Estelle Study 55
Oct 30, 2017: Mithra Completes Recruitment for Estelle Phase III Study in US & Canada 56
Oct 30, 2017: Mithra Completes Recruitment for Estelle Phase III Study in US and Canada 57
Aug 18, 2017: Mithra Announces First Subject Completes Estelle Phase III Study 58
Aug 09, 2017: Mithra Pharmaceuticals: Recruitment Completed in Estelle Population PK Substudy 59
Jul 06, 2017: Mithra Strengthens E4 Patent Position in Australian Market 60
Jun 26, 2017: Estelle Phase IIB Results on Well-Being and Body Weight Published in Leading Peer-Reviewed journal 61
Jun 21, 2017: Mithra Completes Recruitment For Additional Estelle Safety Study 62
May 12, 2017: Mithra to Initiate PK Study for Estelle 63
Feb 07, 2017: Mithra Completes Recruitment For European Phase III Estelle Study 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Deals By Therapy Area, 2012 to YTD 2018 9
Mithra Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 10
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mithra Pharma Acquires Estetrol from Pantarhei Bioscience 13
Mithra Pharma Acquires Women Health Portfolio from Uteron Pharma 14
Mithra Pharma Enters into Agreement with Generic Specialty Pharma 15
Pei Li Pharma Enters into Licensing Agreement with Mithra Pharma 16
Richter Gedeon Enters into Licensing Agreement with Mithra Pharma 17
Mediner Enters into Licensing Agreement with Mithra Pharma 18
Searchlight Pharma to Enter into Licensing Agreement with Mithra Pharma 19
Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 20
Fuji Pharma Enters into Licensing Agreement with Mithra Pharma for Donesta 21
Mithra Pharma Enters into Licensing Agreement for Tibelia in Canada 22
Mithra Pharma Raises USD90 Million in Private Placement of Shares 23
Mithra Pharma Raises USD29 Million in Private Placement of Shares 25
Mithra Pharma Raises USD81.4 Million in IPO 26
Ceres Pharma to Acquire Women's Health Generic Business from Mithra Pharma 27
Mithra Pharmaceuticals SA, Key Competitors 28
Mithra Pharmaceuticals SA, Key Employees 29
Mithra Pharmaceuticals SA, Subsidiaries 30

List of Figures
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Mithra Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Mithra Pharmaceuticals SA (MITRA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Longfor Properties Co., Ltd.:戦略・SWOT・企業財務分析
    Longfor Properties Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Longfor Properties Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • El Paso Electric Company:企業の発電所・SWOT分析2018
    El Paso Electric Company - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Recursion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Recursion Pharmaceuticals Inc (Recursion Pharmaceuticals) is a biotechnology company that develops novel therapies for the treatment of rare genetic diseases. The company’s pipeline products include novel drugs for various diseases such as ataxia-telangiectasia, cerebral cavernous malformati …
  • Publix Super Markets Inc:企業の戦略的SWOT分析
    Publix Super Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Sotera Health LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • Virgin Active Limited
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tyser & Co Limited:企業の戦略的SWOT分析
    Tyser & Co Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Relievant MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Relievant MedSystems Inc (Relievant) is a medical device company developing new minimally-invasive solutions for the treatment of chronic low back pain (CLBP). The company's Intracept system, a minimally invasive procedure uses radiofrequency energy delivered through a small access tube into …
  • Steinhoff International Holdings NV (SNH):企業の財務・戦略的SWOT分析
    Steinhoff International Holdings NV (SNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Aurora Diagnostics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurora Diagnostics LLC (Aurora Diagnostics) is a healthcare service provider that offers hospital and pathology services. The center’s pathology services include gastrointestinal pathology services, heamato-pathology services, dermatology services, urologic pathology, pathology consultation, …
  • Bronzeoak Philippines Inc:電力:M&Aディール及び事業提携情報
    Summary Bronzeoak Philippines Inc (Bronzeoak), a subsidiary of AC Energy Holdings Inc, is a renewable energy company that develops, implements and manages energy projects. The company provides sugar manufacturing, ethanol production, power generation and biofuels supply services, among others. It de …
  • SKYCITY Entertainment Group Ltd:企業の戦略・SWOT・財務情報
    SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polyme …
  • Program for Appropriate Technology in Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Program for Appropriate Technology in Health (PATH) is a non-profit organization that improves health in women and children. The organization offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. It develops diagnostics for HIV and other …
  • Tristan Technologies Inc:企業の製品パイプライン分析
    Summary Tristan Technologies Inc (Tristan) is a medical device company that offers laboratory products. The company designs, develops and manufactures components and systems for biomagnetic measurement and clinical applications. Its products comprise biomagnetic devices, geomagnetic, cryogenic, non- …
  • ABB Ltd (ABBN):石油・ガス:M&Aディール及び事業提携情報
    Summary ABB Ltd (ABB) is a provider of industrial technologies. It offers products, systems, solutions, and services in electrification products, motion, industrial automation, industrial automation, and power grids. The company’s offerings harness power reliability, increase industrial productivity …
  • The Timken Company:企業の戦略・SWOT・財務情報
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CommScope Holding Company Inc:企業のM&A・事業提携・投資動向
    CommScope Holding Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CommScope Holding Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Pioneer Natural Resources Co (PXD):企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆